Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2002
10/02/2002CN1371914A Cockroach polypeptide tracted from cockroach and extraction method thereof
10/02/2002CN1371903A Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity
10/02/2002CN1371749A Biological therapy adjuvant originated from animal Chinese medicine
10/02/2002CN1371741A Chinese medicine injection for stopping cancer pain
10/02/2002CN1371729A Anti-cancer recovery capsule and preparation process thereof
10/02/2002CN1371725A Capsule for treating AIDS and tumor and preparation process thereof
10/02/2002CN1371723A Anti-tumor and antiviral medicine and production method thereof
10/02/2002CN1371715A Powder medicine for treating mammary cancer
10/02/2002CN1371711A Medicine for treating mammary cancer
10/02/2002CN1371704A Medicine for treating digestive system disease and tumor and preparation method thereof
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/02/2002CN1371684A Novel biological activity of proglumide
10/02/2002CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors
10/02/2002CN1091766C Prenyl transferase inhibitors
10/02/2002CN1091601C Use of phenol substituted diphosphonates as antineoplastic agents
10/01/2002US6459003 Ether compounds
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance
10/01/2002US6458925 Peptide antagonists of zonulin and methods for use of the same
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458816 Anticancer agents
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458800 1,2-annelated quinoline derivatives
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458783 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
10/01/2002US6458765 Polypeptides as anticancer agents and against cell proliferation
10/01/2002US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002US6458561 Human NIM1 kinase
10/01/2002US6458389 Microgranules containing cisplatin
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458369 Composition comprising tumor cells and extracts and method of using thereof
10/01/2002US6458368 As vaccines for immunization
10/01/2002US6458364 Non-splicing variants of gp350/220
10/01/2002US6458356 Antibody-induced apoptosis
10/01/2002US6458351 Yeast extracts
10/01/2002CA2224460C Process for producing gm2 specific antibodies
10/01/2002CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2119930C Production of chimeric antibodies - a combinatorial approach
10/01/2002CA2069244C Drug-containing protein-bonded liposome
10/01/2002CA2065104C Erucyl, brassidyl and nervonyl derivatives
09/2002
09/26/2002WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1
09/26/2002WO2002074945A1 Method for cleaving human growth hormone gh
09/26/2002WO2002074940A1 Method of extracting virus from cell culture
09/26/2002WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
09/26/2002WO2002074937A1 Method of differentiating immature liver cells by using extracellular matrix
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074835A1 Process for producing lactic acid oligomer
09/26/2002WO2002074806A2 New interferon beta-like molecules
09/26/2002WO2002074805A1 Soluble rage protein
09/26/2002WO2002074798A2 The genome of a bifidobacterium
09/26/2002WO2002074776A2 Highly purified and crystalline form of harringtonine
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074765A1 Phenyl derivatives 3
09/26/2002WO2002074759A1 Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074756A2 Urokinase inhibitors
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074747A1 Farnesyltransferase inhibitors
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002WO2002074736A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
09/26/2002WO2002074735A2 Biurethane derivatives
09/26/2002WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002WO2002074725A1 Novel ligands of nuclear receptor superfamily, process for producing the same and use thereof
09/26/2002WO2002074346A2 Targeting chemical compounds to cells
09/26/2002WO2002074344A2 Peg-conjugates of hgt-nk4
09/26/2002WO2002074338A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells
09/26/2002WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074314A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074309A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
09/26/2002WO2002074304A2 Composition containing a gallium (iii) complex and a therapeutically effective cytostatic agent
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074291A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
09/26/2002WO2002074289A2 Antitumor compositions containing taxane derivatives
09/26/2002WO2002074251A2 Monoclonal antibody therapy for pancreas cancer
09/26/2002WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/26/2002WO2002074246A2 Method and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
09/26/2002WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
1 ... 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 ... 2211